In its debut trading on Wednesday, March 31 Achilles Therapeutics, Inc. (ACHL) decreased 8.06% and closed at $16.55 per share. Shortly before the company had placed its shares in IPO priced $18 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей